Hepatocellular carcinoma: Difference between revisions
Adeel Jamil (talk | contribs) |
Simrat Sarai (talk | contribs) No edit summary |
||
Line 15: | Line 15: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma | {{SK}} Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma; hepatic cancer | ||
==[[Hepatocellular carcinoma overview|Overview]]== | ==[[Hepatocellular carcinoma overview|Overview]]== |
Revision as of 18:58, 31 August 2015
Hepatocellular carcinoma | |
Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein | |
ICD-10 | C22.0 |
ICD-9 | 155 |
ICD-O: | 8170/3 |
MedlinePlus | 000280 |
Hepatocellular carcinoma Microchapters |
Differentiating Hepatocellular carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma; hepatic cancer
Overview
Historical perspective
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical therapy: Percutaneous ethanol injection | Transcatheter arterial chemoembolization (TACE) | Sealed source radiotherapy | Radiofrequency ablation (RFA) | Intra-arterial iodine-131–lipiodol administration | High intensity focused ultrasound (HIFU) | Hormonal therapy | Chemotherapy
Contraindicated medications
Hepatocellular carcinoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol
- Hydroxyprogesterone caproate
Surgery: Liver transplant | Surgical resection | Cryosurgery
Prevention: Primary prevention | Secondary prevention
Resources
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology
de:Leberzellkarzinom fi:Maksasyöpä hr:Rak jetre hu:Májtumor la:Carcinoma hepatocellulare ko:간암 nl:Leverkanker no:Leverkreft sv:Levercancer